UNH price forecast: stock consolidates near $322.92

Traders Union
All News
Financial News
UnitedHealth Group slips 0.42% today

Highlights

UnitedHealth Group closed at $322.92, remaining below its MA-20, MA-50, and MA-200, with technicals and oscillators indicating persistent bearish momentum and oversold conditions.
UnitedHealth Group reported Q3 revenue of $113.16 billion, raised its 2025 earnings outlook, and declared a $2.21 per share cash dividend payable December 2025, marking 15 consecutive annual increases.
The adjusted trading range for UNH next week is $315.00 to $326.00, with less than 20 probability of a sustained price increase and likely further downside if $320.00 support breaks.

Earnings beat and dividend growth as institutional flows shift amid headwinds

UnitedHealth Group reported third-quarter revenue of $113.16 billion and raised its full-year 2025 earnings outlook, marking a solid financial performance. The company declared a $2.21 per share cash dividend to be paid in December 2025, extending its 33-year streak of dividend payments and 15 consecutive years of increases. Recent SEC filings highlight notable institutional activity, including significant increases by Allworth Financial LP, Summit X LLC, and Smead Capital Management, as well as new positions and some reductions among other investment firms. The company continues to face industry headwinds related to cost management, regulatory changes, and evolving Medicare reimbursement models.

Sustained bearish momentum persists as multiple signals confirm oversold state

At $322.92, UNH trades well below its MA-20 ($351.04), MA-50 ($345.84), and MA-200 ($381.52), indicating sustained bearish pressure in the short, medium, and long term. The closest dynamic resistance is found at the Ichimoku Kijun level near $347.59, while the price is currently far below major moving averages. Momentum indicators show continued weakness with the MACD on daily and weekly timeframes in strong sell territory and ADX levels confirming a lack of strong bullish reversal. Multiple oscillators (RSI at 32.46, Stoch RSI at 8.76, and CCI at -155.17) signal oversold conditions, yet the BBP also points to sellers dominating the session. The Awesome Oscillator supports the bearish trend. UNH slipped 0.42% today, opening $2.00 lower than the previous close, showing a small gap down, and currently trades mid-range within the $320.28–$324.22 band. Intraday volatility is low, with persistent pressure after the open. Although the market appears oversold, the momentum remains negative with minor divergence among oscillators, suggesting limited buying interest.

Limited upside as expected range tightens and downside risks remain

For the upcoming week, the adjusted expected trading range for UNH is $315.00 to $326.00, closely hugging the current price in line with typical blue-chip stock volatility. There is a very low probability (less than 20%) of a sustained price increase, making a further decline much more likely. The baseline scenario is for UNH to consolidate sideways within the corridor as oversold conditions persist. A bullish scenario would require a breakout above the $347.59 resistance, invalidating current momentum. The bearish scenario involves a decisive move below $320.00, exposing further downside toward medium-term support.

Anton Kharitonov, expert at Traders Union, sees ongoing bearish momentum in UnitedHealth Group despite solid revenue and a continued dividend streak. He notes that technical weakness persists and institutional activity is mixed, while industry headwinds remain significant. Base case is for a sideways range unless key resistance at $347.59 is reclaimed. "Until the price breaks decisively above $347.59, I remain cautious and see limited upside for now."

Previously it was noted that the asset remains under all key moving averages, with momentum indicators confirming strong bearish sentiment. The outlook referenced further downside risk builds as rebound chances stay limited, particularly amid oversold conditions and persistent selling pressure.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.